Package 68462-621-02

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "b8ebbf3b-dba3-43b2-aae1-8bb71e460476", "openfda": {"upc": ["0368462622643", "0368462621547"], "unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670200"], "spl_set_id": ["a0def32c-e693-43e5-9509-0cef9642441c"], "manufacturer_name": ["GLENMARK PHARMACEUTICALS INC., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL, SINGLE-DOSE in 1 CARTON (68462-621-02)  / 2 mL in 1 VIAL, SINGLE-DOSE (68462-621-54)", "package_ndc": "68462-621-02", "marketing_start_date": "20231013"}], "brand_name": "Fosphenytoin sodium", "product_id": "68462-621_b8ebbf3b-dba3-43b2-aae1-8bb71e460476", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68462-621", "generic_name": "Fosphenytoin sodium", "labeler_name": "GLENMARK PHARMACEUTICALS INC., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fosphenytoin sodium", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "ANDA214926", "marketing_category": "ANDA", "marketing_start_date": "20231013", "listing_expiration_date": "20261231"}